Identification of UNC119 as a Novel Activator of SRC-type Tyrosine Kinases*

Osman CenDagger §, Magdalena M. GorskaDagger , Susan J. StaffordDagger , Sanjiv SurDagger , and Rafeul AlamDagger §||

From the Dagger  Division of Allergy and Immunology, NIAID, National Institutes of Health Asthma and Allergic Diseases Research Center, Department of Internal Medicine, and the § Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555

Received for publication, August 13, 2002, and in revised form, December 5, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Lyn, an Src-type tyrosine kinase, is associated with the interleukin (IL)-5 receptor in eosinophils. The mechanism of its activation is unknown. Through yeast two-hybrid screening we have cloned and characterized a new signaling molecule, Unc119, that associates with IL-5Ralpha and Src family tyrosine kinases. Unc119 induces the catalytic activity of these kinases through interaction with Src homology 2 and 3 domains. IL-5 stimulation of eosinophils increases Unc119 association with Lyn and induces its catalytic activity. Lyn is important for eosinophil survival. Eosinophils that are transduced with Unc119 have increased Lyn activity and demonstrate prolonged survival in the absence of IL-5. Inhibition of Unc119 down-regulates eosinophil survival. To our knowledge Unc119 is the first receptor-associated activator of Src family tyrosine kinases.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

One of the fundamental goals of cell biology is to understand the mechanism of signal generation by receptors. Many receptors rely upon kinases, especially tyrosine kinases, for receptor phosphorylation and activation of signaling cascades. The Src family tyrosine kinases (SrcTKs)1 frequently serve as the trigger mechanism for cytosolic signals (1). Receptor-associated SrcTKs exist in a non-active conformation and become transiently activated following ligand binding and receptor oligomerization (2). How receptor oligomerization leads to the activation of SrcTKs is unknown.

Two intramolecular interactions tightly regulate structural conformation and enzymatic activity of SrcTKs. One is through Src homology 2 (SH2) and the other is through the SH3 domain. All cellular SrcTKs have a C-terminal regulatory tyrosine residue (Tyr527 for Src). Phosphorylated Tyr527 forms an intramolecular interaction with the SH2 domain of the kinase (3). This interaction decreases the kinase activity. Dephosphorylation of this tyrosine residue by phosphatases such as CD45 is required but is not sufficient for kinase activation (4). Receptor-bound SrcTKs are frequently found to be dephosphorylated under basal conditions, yet lack appreciable catalytic activity (5). CD45-negative cells have variable effects on SrcTKs. CD45 negatively regulates Lyn by dephosphorylating both its negative and positive regulatory tyrosine residues (6). The activity of Lyn and Hck is increased in macrophages (7) and B cells (8) lacking CD45.

Regulation of SrcTK activity through other intramolecular interactions was realized after the crystal structures of Src (9) and Hck (10) were solved. The linker region that is located between the SH2 and the kinase domains binds to the SH3 domain of the kinase rendering a non-active conformation. Furthermore, a short amino acid stretch connecting the SH2 and SH3 domains has recently been identified as an additional negative regulator of Hck and Src activation (11). The SH3 domain of SrcTKs prefers to bind to the RXXPXXP motif (a motif is defined as a short stretch of amino acid residues that binds to a signaling domain) (12, 13). Although the linkers of SrcTK bind to the SH3 domain, they do not have an optimal SH3-binding motif. Src and Fyn do not even have the second proline residue in the motif (13). Although Lyn has the canonical PXXP motif (amino acids 230-233) like all other SrcTKs, it lacks the flanking arginine residue. This "imperfect" SH3 motif with low affinity binding can be easily displaced by a high affinity SH3 ligand. Accordingly, the exogenous SH3 ligand Nef (a human immunodeficiency virus protein) activates Hck, a member of SrcTKs, in an SH3 motif-dependent manner (14). However, the identity of endogenous SH3 ligands that activate SrcTKs is largely unknown.

Our laboratory has been interested in the signal transduction mechanism of IL-5R, which is composed of a unique alpha  and a common beta  subunit (15). The earliest event of IL-5R signaling in eosinophils is the activation of SrcTKs and Janus kinases (16-18). One of the SrcTKs that plays a dominant role in eosinophils is Lyn kinase. We and others (19-21) have shown that Lyn is important for eosinophil survival and differentiation. The molecular mechanism of activation of Lyn kinase by IL-5 receptor is unknown.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Yeast Two-hybrid Screening-- A human fetal cDNA library (Clontech) was screened using the LexA Matchmaker Yeast Two-hybrid System (Clontech). The bait was constructed by fusing the cytosolic and transmembrane portion of IL-5Ralpha in-frame with LexA DNA binding domain in pLexA plasmid. The cytosolic portion of IL-5Ralpha (98 amino acids) was PCR-amplified from IL-5Ralpha cDNA (a kind gift from Dr. J. Tavernier) using AGCGAATTC-AGTGAGTGGAGCCAACCTA and AGAGGATCC-GCATGTGTGAGTTCATCAG as 5' and 3' end primers, respectively, and ligated into pLexA after EcoRI and BamHI restriction enzyme (Invitrogen) reactions. The correct reading frame was confirmed by sequencing. The bait construct and the fetal human cDNA library in the pB42AD (Clontech) were cotransformed into EGY48 yeast strain carrying the reporter plasmid p8opLacZ. A set of negative and positive controls was carried out according to the protocol provided. The transformed colonies were grown on SD/-His-Trp-Ura selection plates for 5 days. The colonies were then replica-plated on induction plates SD/Gal-Raf-His-Leu-Trp-Ura plates containing 5-bromo-4-chloro-3-indolyl-beta -D-galactopyranoside (X-gal) (Invitrogen). The grown blue colonies on induction plates were streaked on selection plates and then again on induction plates to allow possible plasmid segregation and eliminate transition interactions. A stock for each of the double positive colonies (Leu+, LacZ+; grown blue colonies) was prepared and stored at -80 °C. These colonies then were individually cultured in SD/-Trp media overnight for plasmid segregation and selection for pB42AD-cDNA constructs. The plasmid DNA was isolated (22) and electroporated (23) into Escherichia coli KC8 cells. The transformants carrying pB42AD-cDNA were selected on M9/-Trp/Amp plates for two rounds followed by plasmid purification. The plasmids were purified from individual colonies using QIAprep Spin Miniprep kit (Qiagen) and were cut with EcoRI and XhoI restriction enzymes (Invitrogen) for confirmation of cDNA inserts which was then partially sequenced using pB42AD sequencing primers at the University of Texas Medical Branch Molecular Biology Core Lab. The partial sequence of each colony was searched for homology to known sequences with the BLAST program (www.ncbi.nlm.nih.gov/BLAST) with non-redundant data base.

Primers, RT-PCR, and Southern Hybridization-- Primers were designed using the Primer Designer software (1990-1991 Scientific and Educational software) and synthesized at the University of Texas Medical Branch Molecular Biology Core Lab. The PCRs were carried out in a thermocycler (Idaho Technology) in capillary tubes. For RT-PCR, total RNA was purified from eosinophils using TRIzol (Invitrogen). Twenty nanograms of RNA was reverse-transcribed into cDNA using Superscript II preamplification kit (Invitrogen) following the protocol provided. PCR amplification was performed using CCGCAAGGCCATGAAGGTGA and CAGTGCCTGAGTCCATGTCC as 5' and 3' primers, respectively. The PCR mixture was separated on 3% NuSieve 3:1 agarose gel (FMC Bioproducts) and then either transferred to nylon membrane (Schleicher & Schuell) and hybridized with 32P-labeled (Amersham Biosciences) Unc119 (labeled with DECAprime II kit, Ambion) or the corresponding ~200-bp band was excised, purified, sequenced, and aligned with that of Unc119 with the BLAST2 program (www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html).

Expression and Purification of Recombinant Unc119-- The encoding cDNA sequence of Unc119 was PCR-amplified using GGCGAATTC-CCATGAAGGTGAAGAAGG and AATGTCGA-CGTGGGATCAGGGTGT as 5' and 3' end primers, respectively. The PCR fragment was fused in-frame into pGEX-4T2 (Amersham Biosciences) after EcoRI and SalI restriction (Invitrogen) reactions. After the correct reading frame was confirmed with sequencing, it was electroporated into the E. coli BL21 strain. The expression and purification of the recombinant Unc119 was performed with the modification of the protocol provided. Briefly, the transformed cells were grown in 2× YTA medium overnight with 200 rpm shaking at 37 °C. The overnight culture was diluted 1:100 and incubated at 25 °C with shaking until the A600 reached ~1.50. At this time the isopropyl-1-thio-beta -D-galactopyranoside (Invitrogen) was added to a final concentration of 0.1 mM and incubated for 4 h. The cells were then pelleted, resuspended in ice-cold PBS, and sonicated. Triton X-100 (Sigma) was added to a final concentration of 1% and was mixed and centrifuged at 12,000 × g, 4 °C, for 10 min. The recombinant protein was batch-purified with glutathione-agarose (Santa Cruz Biotechnology). One ml of glutathione-agarose was added to 25 ml of sonicate and incubated at room temperature for 1 h with rotation. The mixture was centrifuged at 5,000 × g for 5 min. The pellet was washed 5 times with 20 ml of PBS and was eluted with elution buffer (10 mM reduced glutathione in 50 mM Tris-HCl, pH 8; 1 ml of elution buffer per 1 ml of glutathione-agarose used). In some cases it was subjected to thrombin cleavage before elution. 100 cleavage units of thrombin (Amersham Biosciences) was added to 5 mg of GST-Unc119 and incubated at 22 °C with rotation for 20 h. The GST then was separated by glutathione-agarose pull-down. The supernatant containing cleaved Unc119 was aliquoted and stored at -20 °C. The purity of GST-Unc119 and Unc119 was assessed with Coomassie Blue staining. The amount of recombinant or lysate protein was determined with Coomassie Plus Protein Assay Kit (Pierce) following the protocol provided.

Peptide Synthesis and Antibody Generation-- Experiments were performed according to the protocols of The Animal Resources Center and the Institutional Animal Care and Use Committee at the University of Texas Medical Branch. All peptides were synthesized at the Protein Biochemistry Core Lab of the University of Texas Medical Branch. A sequence of an immunogenic peptide from Unc119 was determined by hydropathy plot using Protscale at the Expasy site (www.expasy.ch/cgi-bin/protscale.pl). The peptide was synthesized and conjugated to keyhole limpet hemocyanin (Pierce) according to the protocol provided. The peptide-keyhole limpet hemocyanin conjugate (300 µg) or whole recombinant Unc119 (200 µg) was mixed with either Imject Alum (Pierce) or Titermax Gold (Sigma) as adjuvant and injected into a New Zealand White rabbit subcutaneously after obtaining a sample of pre-immune serum. Three booster injections were performed at the 4th, 6th, and 8th weeks after first immunization. A blood sample was drawn before each booster and 2 weeks after the third booster (10th week). The serum was obtained according to Ref. 24. Briefly the blood was kept at room temperature for 4 h and then at 4 °C overnight. The serum was centrifuged at 12,000 × g at 4 °C to precipitate any particulate and aliquoted and stored at -20 °C until use.

Eosinophil and Mononuclear Cell Purification and Stimulation-- All experiments were conducted in compliance with the Institutional Review Board protocol. Eosinophils were purified as described (17). In short, peripheral blood from volunteers was left at room temperature in 1.2% Hetastarch, 25 mM EDTA for 30 min. The buffy coat was transferred into new tubes and washed 2 times with Hanks' balanced saline solution before Percoll gradient (Amersham Biosciences) centrifugation. The polymorphonuclear fraction was taken, and the red blood cells were lysed with hypotonic shock. Eosinophils were negatively selected after incubation with anti-CD16 antibody-coated microbeads and passage through a magnetic column (Miltenyi Biotec). In some experiments the mononuclear cell fractions were used as the source of lysates. When needed the cells were cultured in RPMI and stimulated with 10 ng/ml IL-5.

Immunoprecipitation, Gel Electrophoresis, and Western Blotting-- The immunoprecipitation was performed as explained (17). Shortly, the stimulated and non-stimulated cells were lysed in the lysis buffer containing 50 mM Tris-HCl, pH 7.4, 75 mM NaCl, 1 mM EDTA, 1 mM NaF, 1 mM Na3VO4, 0.5% Nonidet P-40, 1 µg/ml each of the protease inhibitors aprotinin, leupeptin, and pepstatin, and 1 mM phenylmethylsulfonyl fluoride. After incubation on ice for 30 min, detergent-insoluble materials were removed by centrifugation at 4 °C at 12,000 × g. After preclearing, 1-2 µg of an appropriate antibody was added to the lysate and incubated at 4 °C rotating for 1 h followed by addition of 20 µl of protein A/G-agarose. The incubation was continued for 2 h or in some cases overnight. The mixture was centrifuged at 12,000 × g for 5 min, and the pellet was washed with 1 ml of lysis buffer 5 times or 3 times with lysis buffer and 3 times with kinase buffer in the case of kinase reactions. The samples were separated with SDS-PAGE and blotted onto nitrocellulose or PVDF membranes for immunoblotting. The membranes were incubated in 5% non-fat dried milk or 5% bovine serum albumin in TBS-T buffer followed by incubation in the primary antibody solutions at a concentration of 0.01-0.03 µg/ml in 2% bovine serum albumin/TBS-T. The membranes were then washed 3 times in the TBS-T buffer for 10 min each and incubated with horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology) solution (0.01 µg/ml). After washing again the membranes were developed with enhanced chemiluminescence (ECL or ECL Plus) substrate (Amersham Biosciences). To strip and reprobe, the membranes were incubated in the stripping buffer (100 mM 2-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl, pH 6.7) at 55 °C for 30 min, washed, blocked, and immunoblotted with a proper antibody as explained above. Densitometric analyses of select Western-blotted protein bands were performed with the software "Metamorph" version 6.4r8 (Universal Imaging Corporation, Downingtown, PA).

GST Pull-down-- GST or GST fusion proteins (Unc119 or Lyn) were incubated with the cell lysates or recombinant Unc119 at 4 °C rotating for 2 h. Twenty µl of glutathione-agarose was then added, and incubation was continued for 2-4 h or overnight. The samples were centrifuged at 12,000 × g for 5 min, and the pellets were washed with lysis buffer, separated with SDS-PAGE, transferred to PVDF membrane, and Western-blotted.

In Vitro Kinase Assay-- To assess the effect of Unc119 on the activation of individual kinases, Lyn, Hck, Itk, or p38 was immunoprecipitated with respective antibodies (Santa Cruz Biotechnology) in bulk from the mononuclear cell lysates. The respective kinases were immunoprecipitated from the lysates corresponding to 50-60 million cells, aliquoted in 20-30 samples, and kept at -80 °C for future kinase assays. The kinase assays were performed in the presence or absence of Unc119 or its SH3 motif (PSH3, QRKQPIGPED), proline to alanine mutant (PP-A, QAKQAIGAED), SH2 motif (PSH2, TCEHIYDFPPLS), phosphorylated SH2 motif (pPSH2, TCEHIpYDFPPLS), an immunogenic peptide (PC, SERLPINRRDLDPNAGRC), or an SH3 peptide from CD2 (CD2 PSH3, QKGPPLPRPRVQPKPPCG) (28) in a kinase buffer containing 20 mM Tris, pH 7.4, 2 mM MgCl2, 0.5 µM cold ATP, and 2 µCi of [gamma -32P]ATP for 5 min. In the reactions in which the effect of Unc119 on the activation of Lyn was evaluated, 2 µM Enolase (Sigma) or ATF-2 (Santa Cruz Biotechnology) was added to the reactions as the substrate. This buffer was modified from Moarefi et al. (14) to decrease the high base-line phosphorylation of Lyn. The reactions were carried out at 30 °C for different times and were stopped by addition 6× Laemmli's buffer. The reactions then were separated by SDS-PAGE, transferred to PVDF membrane, and autoradiographed.

Chariot Protein Transduction-- Purified eosinophils (>98%) were used for Unc119 or anti-Unc119 antibody (affinity-purified) transduction experiments. HSA and purified rabbit IgG were used as controls for Unc119 and anti-Unc119 antibody, respectively. TF-1 cells were used for transduction with FITC-labeled ovalbumin (Molecular Probes, Eugene, OR). For each reaction 6 µl of Chariot (Active Motif, Carlsbad, CA) suspension was diluted to 100 µl with H2O, combined with Unc119 or HSA (0.5 and 5 µg/106 cells), or anti-Unc119 antibody or rabbit IgG (2, 4, and 6 µg per 106 cells), resuspended in 100 µl of PBS, and incubated at room temperature for 30 min. After 2 washes in PBS, 1 × 106 cells were resuspended in 200 µl of Chariot-protein complex. After the addition of 400 µl of RPMI, the cells were incubated for 1 h at 37 °C. Fetal calf serum and RPMI were then added to bring final transfection volume to 1 ml at 5% fetal calf serum. The cells were incubated for an additional 2 h. IL-5 was added to appropriate cells at 1 × 10-10 M, and cells were stimulated for 5 min or cultured overnight. The cells were then lysed for kinase assays or used for survival/apoptosis assay.

Measurement of Apoptotic Eosinophils by Flow Cytometry-- Cells were washed twice in PBS and then resuspended in Binding Buffer (10 mM HEPES, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) at 1 × 106 cells/ml according to the manufacturer's protocol for annexin V staining (BD Biosciences). Five µl of annexin V FITC and 6 µl of 50 µg/ml propidium iodide (Sigma) were added to 100 µl of cell suspension. Cells were gently mixed and incubated 15 min at room temperature in the dark. After adding 400 µl of Binding Buffer to each tube, the samples were analyzed by flow cytometry.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Construction of Bait and Cloning Unc119-- In order to search for IL-5Ralpha -interactive signaling molecules, we have used the LexA Matchmaker Yeast Two-hybrid System. We constructed the bait pLexA-5Ralpha by fusing the cytoplasmic tail of IL-5Ralpha to the DNA binding domain of LexA. By using this bait, we have screened the human fetal liver cDNA library for IL-5Ralpha interacting proteins. One of the cDNAs was HRG4/human Unc119 (98% homology) (GenBankTM accession number U40998) with a 1.4-kbp cDNA and a 240-amino acid open reading frame (25).

Unc119 Is Expressed in Eosinophils and Mononuclear Cells-- Unc119/HRG4 was shown previously (25) to be preferentially expressed in retina. However, its expression in hematopoietic cells was not studied. Because we cloned it from fetal liver, an early hematopoietic organ, we critically examined its expression in myeloid cells. We demonstrated the presence of its message in eosinophils by RT-PCR followed by Southern hybridization (Fig. 1A). We subcloned the RT-PCR-amplified Unc119 cDNA and confirmed its identity by sequencing (data not shown). We raised a rabbit polyclonal antibody and used it to detect the presence of Unc119 in eosinophils, mononuclear cells, and polymorphonuclear granulocytes by Western blotting. Immune serum but not the preimmune serum detected two bands of proteins of approximate molecular mass of 37 and 39 kDa (Fig. 1B, left panel). In order to identify the exact Unc119 band, we depleted the anti-Unc119 antibody from the immune serum by incubating the latter with excess amounts of GST-Unc119. The anti-Unc119-depleted serum failed to stain the lower band (37 kDa) but not the upper band (Fig. 1B, right panel). The depleted serum also failed to detect recombinant Unc119 that was loaded in the 1st lane. The results suggest that our antibody detects a 37-kDa Unc119 protein, which is expressed in myeloid and lymphoid cells. By using this antibody we Western-blotted tissue lysate from mouse retina, heart, liver, lung, and spleen. As reported, Unc119 was predominantly expressed in the retina (Fig. 1C). However, small detectable amounts of Unc119 were also present in other organs.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 1.   Unc119 is expressed in hematopoietic cells and interacts with the IL-5 receptor. A, Unc119 mRNA expression in eosinophils. Total RNA from eosinophils was reverse-transcribed into cDNA (RT-PCR). In the control reaction (NO-RT) reverse transcriptase was omitted from the reaction. For a positive control, we PCR-amplified (PCR) Unc119 from pB42AD-Unc119. The reaction mixtures were separated, transferred to a nylon membrane, and probed with 32P-labeled Unc119 cDNA followed by autoradiography. B, Western blot showing the expression of Unc119 in hematopoietic cells. Cell lysates from eosinophils (Eos), mononuclear cells (MNC), and polymorphonuclear leukocytes (PMN) were separated by SDS-PAGE and Western-blotted (WB) with preimmune and rabbit anti-Unc119 antibody (left panel). Another sample of the cell lysates were Western-blotted (right panel) with the anti-Unc119 antibodies (alpha -Unc119) or the anti-Unc119 antibody-depleted serum (alpha -Unc119 depleted) (n = 3). C, comparison of Unc119 expression in various mouse organs. Tissue lysates (60 µg of protein) from retina, heart, liver, lung, and spleen was directly Western-blotted. The last lane shows the position of rUnc119. D, Unc119 interacts with IL-5Ralpha in the yeast. pLexA-5Ralpha and pB42AD-Unc119 constructs were transfected into the yeast EGY48 alone or together and plated first on selection and then on induction plates and were checked for the activation of the reporter gene lacZ. 53-T (pLexA-53 + pB42AD-T) and Pos (pLexA-53 fused to AD-T) were positive and Lam (pLexA-53 + pB42AD-Lam) was a negative control for the experiment (n = 2). E, Unc119 is associated with IL-5Ralpha but not with common beta c chain in eosinophils. Lysates from non-stimulated or IL-5-stimulated eosinophils were immunoprecipitated (IP) with either anti-IL-5Ralpha or anti-beta c antibodies and Western-blotted with anti-Unc119 antibody (above). In the 1st lane rUnc119 (50 ng) was loaded alone in order to identify the position. The same membrane was stripped and reprobed with either anti-IL-5Ralpha (lower right) or with anti-beta c (lower left) antibodies (n = 3).

Unc119 Is Associated with IL-5Ralpha -- We reconfirmed the interaction of IL-5Ralpha and Unc119 in the yeast. Cotransfection of the bait construct pLexA-5Ralpha and pB42AD-Unc119 into the yeast activated the reporter lacZ gene, indicating the interaction of IL-5Ralpha and Unc119. Neither the bait nor the Unc119 alone activated the reporter gene (Fig. 1D). Next we assessed this interaction in vivo in eosinophils in coimmunoprecipitation experiments. Unc119 was physically associated with IL-5Ralpha in lysates from both IL-5-stimulated and non-stimulated eosinophils (Fig. 1E), which is anticipated from the result of the yeast two-hybrid experiment. Under the same conditions, Unc119 did not associate with the common beta c chain. The anti-beta c antibody is a rabbit antibody and served as a control for the anti-Unc119 antibody.

Unc119 Has SH3- and SH2-binding Motifs-- SH3-binding motifs contain the canonical PXXP sequence (12, 13) that is frequently flanked by a conserved arginine (Table I). Unc119 has one complete and one incomplete SH3-binding motif at the N terminus. It also has phosphorylation sites for SrcTKs and one SH2-binding motif (Table I). The SH2-binding motif (26), which also conforms to the consensus tyrosine phosphorylation site for SrcTKs, is located at the C terminus.

                              
View this table:
[in this window]
[in a new window]
 
Table I
SH2 and SH3 motifs of Unc119

Unc119 Associates with Lyn and Hck-- In the next step we investigated whether Unc119 was associated with SH2 and SH3 domain-containing signaling molecules. For this purpose we examined the association of Unc119 with Lyn, Hck, Itk, and phosphatidylinositol 3-kinase (PI3K) p110gamma . Lyn and Hck are members of SrcTKs and contain SH2 and SH3 domains. Itk is a non-Src tyrosine kinase and has SH2, SH3, and pleckstrin homology domains. The lipid kinase (PI3K) p110gamma contains no SH2 or SH3 domains. The physical association of Unc119 with the foregoing molecules was studied in GST pull-down experiments (Fig. 2). The results show that Lyn and Hck but not Itk or PI3Kgamma associate with Unc119. Lyn exists in two molecular weight isoforms (53 and 56 kDa), and both are coprecipitated with GST-Unc119. In additional studies GST-Unc119 did not associate with FAK, Abl, p85 subunit of PI-3 kinase, Raf-1, ERK and p38 mitogen-activated protein kinase.2


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 2.   Unc119 associates with Lyn and Hck but not with Itk or PI3K. A, GST (G) or GST-Unc119 (G-Unc) were incubated with the whole cell lysate (WCL). The bound proteins were pulled down with glutathione-agarose, separated by SDS-PAGE, and Western-blotted (WB) with the respective antibodies (n = 4). B, the membranes that were Western-blotted with anti-Hck and anti-PI3K antibodies were stripped and reprobed with anti-GST antibodies to confirm the presence and assess the quantity of GST or GST-Unc119 in the binding reactions (n = 2).

Unc119 Associates with Lyn through SH2 and SH3 Domains-- In order to examine the physical association of the native proteins in the cell, we immunoprecipitated Lyn and Western-blotted with the anti-Unc119 antibody (Fig. 3A). As a control for rabbit immunoprecipitating anti-Lyn antibody, we used the anti-beta c antibody. Unc119 coprecipitated with Lyn but not with the control antibody (see also Fig. 1B). The bottom panel shows the amount of Unc119 that did not bind to Lyn and was detectable in the supernatant. The densitometric concentrations of rUnc119 (50 ng), Lyn-bound Unc119, and non-bound Unc119 are 1.4, 0.8, and 1.8 units, respectively. After correcting for the dilution factor of the supernatant (one-fifth of the supernatant was loaded onto the gel), the approximate densitometric concentration of Unc119 in eosinophils (2 × 106) is 9.8 units (Lyn-bound and non-bound). Based upon the densitometric analysis of rUnc119, we calculate that the concentration of Unc119 is ~175 ng/106 eosinophils. This calculation also indicates that about 8% of cellular Unc119 is associated with Lyn kinase. We understand that this is not an accurate estimate of Unc119 concentration because we did not take into account the recovery of cellular Unc119 during lysis and processing.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 3.   Unc119 interacts with Lyn through SH2 and SH3 domains. A, Unc119 coprecipitates with Lyn. An aliquot of IL-5-stimulated eosinophil lysate was incubated with rabbit polyclonal anti-Lyn (alpha -Lyn) or with rabbit polyclonal anti-beta c (alpha -beta c) antibodies and immunoprecipitated (IP). Fifty nanograms of recombinant Unc119 (rUnc), the immunoprecipitated pellets (Pellet, upper panel), or one-fifth of each supernatants (Sup, lower panel) was separated with SDS-PAGE and Western-blotted with anti-Unc119 antibodies (n = 3). B, Unc119 associates with the SH2 and SH3 domains of Lyn. rUnc119 (2 µM) was incubated with 2 µM GST-fused recombinant domains (U, unique N terminus; SH2 and SH3, SH2 and SH3 domains) of Lyn, Grb2, Shc, or Fyn in the lysis buffer, pulled down with glutathione-agarose, and Western-blotted with anti-Unc119 antibody (upper panel). One-fifth of each supernatant was separated on another gel and processed as above (lower panel) (n = 3). C, SH2 and SH3 motif peptides of Unc119 bind Lyn. An aliquot of leukocyte lysate was incubated with no peptide (-) or various concentrations of biotinylated SH3 (PSH3), mutated SH3 in which conserved arginine and proline residues were substituted with alanine (PP-A) (left panel), non-phosphorylated SH2 (PSH2) or phosphorylated SH2 (pPSH2) (right panel) motif peptides, precipitated with streptavidin-agarose, and Western-blotted with the anti-Lyn antibody (Pellet). One-fifth of the supernatant from each sample was also separated and processed as above to confirm the presence of Lyn in the lysates (lower panels, Sup) (n = 3).

Like other SrcTKs, Lyn has a unique domain, followed by a SH3 domain, a SH2 domain, a linker region, and a kinase domain. In order to map the Unc119-binding site of Lyn, we used GST fusion proteins of Lyn unique, SH2, and SH3 domains in a direct binding assay. As controls we used the SH3 domain of Grb2 and the SH2 domain of Shc. Both SH2 and SH3 domains of Lyn were able to associate with rUnc119 (Fig. 3B). The SH2 and SH3 domains of Fyn, another member of SrcTKs, were also able to associate with Unc119 (Fig. 3B). In contrast, the SH3 domain of Grb2 and the SH2 domain of Shc had no or negligible association with Unc119 (Fig. 3B). Direct coprecipitation of GST-Lyn with rUnc119 indicates that the association is not mediated by IL-5R or adapter proteins that might be present in a cell lysate. It is important to note that the binding of the SH2 domain of Lyn to Unc119 occurs in a non-phosphotyrosinedependent manner, because we have used bacterially expressed recombinant Unc119.

In a next set of experiments, we examined whether the SH3 or the SH2 motif peptides derived from Unc119 bind to Lyn kinase. To this goal we synthesized a peptide encompassing the conserved RXXPXXP (residues 55-64) of the SH3 motif of Unc119 (PSH3) and a second peptide that had the conserved arginine and proline residues substituted with alanine (proline to alanine mutant, PPright-arrow A). Similarly we synthesized a third peptide encompassing the SH2 motif of Unc119 (residues 189-200) (PSH2) and a fourth peptide that had the tyrosine residue phosphorylated (pPSH2). The association between the SH2 domains and their cognate SH2 peptide is typically mediated through phosphorylation of the tyrosine residue within the motif peptide. However, several groups (27-29) have reported that this association also occurs independent of phosphorylation. For example, the binding of the SH2 domain of SLAM-associated protein with non-phosphorylated signaling lymphocyte activation molecule (SLAM) peptides has been examined by crystallography, and the nature of the binding interaction has been fully delineated (29). The SH3 motif peptide (PSH3) but not PPright-arrow A was able to associate with and pull down Lyn from the cell lysate (Fig. 3C, left panel). On the other hand, both the phosphorylated and non-phosphorylated SH2 motif peptides bound to Lyn kinase in a dose-dependent manner (Fig. 3C, right panel). It should be noted that the binding through the SH3 domain occurs at much lower concentrations than that through the SH2 domain.

Unc119 Activates Lyn and Hck-- The mechanism of activation of SrcTKs following receptor stimulation is unclear. Because of its interaction with SH3 and SH2 domains, we studied the effect of Unc119 on Lyn and Hck activation. Initially we examined the effect of Unc119 on Lyn autophosphorylation in an in vitro kinase assay. Unc119 stimulated autophosphorylation of Lyn in a dose-dependent manner with the optimum autophosphorylation occurring at a concentration between 7 and 70 nM Unc119 (Fig. 4A). To assess whether the increase in autophosphorylation was associated with enhanced catalytic activity, enolase was used as a Lyn substrate in a similar kinase assay. Unc119 induced enolase phosphorylation by Lyn in a dose-dependent manner (Fig. 4B, left panel). In order to confirm the kinase activity with another substrate, we used Sam68, a known substrate for Src (30). Unc119 was also able to induce the phosphorylation of recombinant Sam68 by Lyn (Fig. 4B, right panel).


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 4.   Unc119 activates Lyn kinase. Lyn was immunoprecipitated from the cell lysates and incubated with rUnc119 (Unc) ± enolase or Sam68 as the substrate in a kinase buffer containing [gamma -32P]ATP for 5 min. The reaction mixtures were separated by SDS-PAGE, transferred to PVDF membrane, and autoradiographed. A, Unc119 induces autophosphorylation of Lyn (n = 3). B, Unc119 induces kinase activity of Lyn for enolase (left) or Sam68 (right) phosphorylation. In the absence of Lyn, Unc119 did not induce the phosphorylation of the substrates (not shown). C, Unc119-derived SH3 motif peptide induces Lyn autophosphorylation and substrate phosphorylation. Immunoprecipitated Lyn was incubated in the kinase buffer with the SH3 (PSH3) or the mutant (PP-A) peptide for 5 min in the absence (left panel) or presence (right panel) of enolase as the substrate. The kinase reactions were separated by SDS-PAGE and autoradiographed (upper panels). The membranes were then Western-blotted with the anti-Lyn antibody (lower panels) (n = 3). D, a CD2-derived SH3 peptide also induced Lyn autophosphorylation (upper panel) and substrate phosphorylation (lower panel). E, Unc119-derived non-phosphorylated (PSH2) or phosphorylated (pPSH2) SH2 motif peptides induce Lyn autophosphorylation and substrate phosphorylation. F, an additional control peptide of similar length from Unc119 (PC) did not activate Lyn.

Next, we investigated the effect of Unc119-derived motif peptides (PSH3, PPright-arrow A, PSH2, and pPSH2) on Lyn activation. The PSH3 peptide induced autophosphorylation of Lyn (Fig. 4C, left panel) and kinase activity for enolase (Fig. 4C, right panel) at low concentrations (0.02 to 0.2 µM). In contrast, the PPright-arrow A peptide induced negligible autophosphorylation and no substrate phosphorylation by Lyn. Previously, a SH3 motif peptide derived from CD2 was shown to induce Fyn activation at relatively high concentrations (1 mM) (31). We tested this peptide for Lyn activation under our assay conditions. This peptide induced autophosphorylation of Lyn (Fig. 4D, upper panel) and kinase activity for enolase (Fig. 4D, lower panel) at >= 20 µM concentration. The Unc119-derived SH3 peptide compares favorably with the CD2 derived SH3 peptide in regard to Lyn activation.

Like the PSH3 peptide, the PSH2 and pPSH2 peptides induced Lyn autophosphorylation at relatively low concentrations (Fig. 4E, left panel). Both SH2 peptides were also able to induce substrate enolase phosphorylation by Lyn, although the PSH2 peptide seems to be more effective than the pPSH2 peptide (Fig. 4E, right panel). An irrelevant peptide (PC) derived from Unc119 did not stimulate enolase phosphorylation by Lyn (Fig. 4F).

To assess whether Unc119 is a specific activator of SrcTKs, we examined the effect of Unc119 and its motif peptides on the kinase activity of Hck, Itk, and p38 mitogen-activated protein kinase (Fig. 5). We chose Itk as a non-Src tyrosine kinase and p38 as a serine/threonine kinase. Unc119, the PSH3 and PSH2 but not the PPright-arrow A or pPSH2 peptide increased Hck activation (Fig. 5A). In contrast, neither Unc119 nor the peptides modified the catalytic activity of Itk or p38 (Fig. 5, B and C). Enolase and transcription factor ATF-2 were used as the substrates for Itk and p38, respectively. Itk from pervanadate-treated mononuclear cells was active and phosphorylated enolase (Fig. 5B). Similarly, p38 from granulocyte-macrophage colony-stimulating factor (GM-CSF)-treated mononuclear cells was active and able to phosphorylate its substrate, ATF-2 (Fig. 5C).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5.   Unc119 activates Hck but not Itk or p38. Immunoprecipitated Hck (A), Itk (B), or p38 (C) was incubated in the kinase buffer ± Unc119 (700 nM) or Unc119-derived peptides (20 µM) in the presence substrates (enolase for Hck and Itk, and ATF for p38, n = 3). Itk from pervanadate-treated and p38 from granulocyte-macrophage colony-stimulating factor (GM-CSF)-treated cell lysates (1st lanes in each panel) were used as positive controls.

IL-5 Stimulates Unc119 Association with Lyn and Its Kinase Activity-- In order to assess the biological relevance of Unc119 in IL-5 signaling, we stimulated eosinophils with IL-5 and examined the association of Unc119 with Lyn and Unc119-bound Lyn activity. IL-5 enhanced the association of Unc119 with Lyn and its catalytic activity (Fig. 6A). The amount of kinase activity that coprecipitated with Unc119 was similar to that associated with the anti-Lyn immunoprecipitate.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 6.   A, IL-5 stimulates Unc119-associated Lyn kinase activity. Eosinophils were incubated with buffer (-) or IL-5 (10-10 M) (+) for 5 min, immunoprecipitated (IP) with the preimmune, anti-Unc119, or anti-Lyn antibodies followed by kinase assay using enolase (Enol) as a substrate. *, Lyn immunoprecipitate was loaded alone in the absence of enolase in the 1st lane in order to identify the position of Lyn kinase. One of two separate experiments is shown. B, protein transduction by Chariot. Cells were incubated with OVA-FITC ± chariot and then examined by flow cytometry. C, activation of Lyn by Chariot-transduced Unc119. Eosinophils were incubated with Chariot and Unc119 (5 µg/106 cells) ± IL-5 (10-10 M) and then lysed, immunoprecipitated with anti-Lyn antibody, followed by kinase assay using enolase as the substrate. One of two separate experiments is shown. D, effect of Unc119 on eosinophil apoptois. Eosinophils were incubated with chariot ± Unc119 or human serum albumin (HSA) (both at 5 µg/106 cells) and then cultured ± IL-5 (10-10 M). Eosinophil apoptosis was assessed by flow cytometry on day 3 following staining for annexin V and propidium iodide. Results of one of two separate experiments are shown.

Transduced Unc119 Activates Lyn and Promotes Cell Survival in the Absence of Growth Factors-- Next, we examined whether Unc119 modulated SrcTK-dependent cellular functions. IL-5 regulates eosinophil survival by activating SrcTKs (19-21) among others. The eosinophil is a terminally differentiated non-proliferating cell and cannot be easily transfected with expression vectors or propagated in selection medium. To overcome this problem we used a new protein transduction reagent called Chariot. This reagent combines the nuclear localization sequences with the retroviral gp41 fusion domain (32). In order to test its capacity to transduce protein into cells, we incubated cells with FITC-labeled ovalbumin in the presence or absence of Chariot. A significant quantity of FITC-labeled ovalbumin was internalized in the presence of Chariot (Fig. 6B). Next, we examined the effect of Unc119 transduction on Lyn kinase activation in eosinophils. Unc119-transduced cells show increased Lyn activation (Fig. 6C), which was comparable with or better than that stimulated by IL-5 (10-10 M). The likely explanation for this strong activation is that we have used a relatively high concentration of Unc119 (5 µg/106 cells) in order to maximize the outcome and to mimic protein overexpression that is typically achieved with expression plasmids. By using this experimental model we studied the effect of Unc119 on eosinophil survival. Unc119 significantly prevented eosinophil apoptosis (Fig. 6D, annexin V- and annexin V+ propidium-positive cells) and increased survival (annexin V and propidium negative cells). In the absence of growth factors 9-16% eosinophils were alive on day 3. The number of live eosinophils was dramatically improved to 70% in Unc119-transduced cells. The effect of Unc119 (5 µg/106 cells) was comparable with that seen with IL-5 (10-10 M). Based upon the results of the kinase experiment (Fig. 6C), we speculate that the transduced Unc119 promoted eosinophil survival by activating Lyn kinase. However, we understand that the effect of interaction of Unc119 with other unidentified signaling molecule(s) in promoting eosinophil survival cannot be ruled out.

Next we studied the effect of the anti-Unc119 antibody on IL-5-stimulated eosinophil survival. Eosinophils were transduced with the affinity-purified anti-Unc119 antibody in the presence of Chariot and then examined for IL-5-stimulated eosinophil survival. The anti-Unc119 antibody (39 versus 84% with IL-5) but not a control IgG (73 versus 84% with IL-5) partially inhibited IL-5-induced eosinophil survival suggesting that Unc119 is physiologically relevant to IL-5 signaling (Fig. 7).


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 7.   The effect of the anti-Unc119 antibody on eosinophil survival. Affinity-purified rabbit anti-Unc119 antibody (raised against full-length recombinant Unc119) or normal rabbit serum IgG (6 µg per 106 eosinophils) were transduced into eosinophils using Chariot as described in Fig. 6. The cells were then cultured with and without IL-5 (10-10 M) for 24 h, and their survival was assessed by flow cytometry after staining with propidium iodide and annexin V. Results of one of three separate experiments are shown.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Lyn, a member of SrcTKs, plays an important role in many hematopoietic cells, especially in B cells (33), mast cells (34), and eosinophils (17). The activation of eosinophils through the IL-5 receptor is critically dependent upon Lyn kinase (19-21). The mechanism of activation of Lyn following receptor stimulation is unknown. We have cloned Unc119 using the IL-5Ralpha subunit as the bait in the yeast two-hybrid screening. Unc119 has SH2- and SH3-binding motifs. It associates with IL-5Ralpha and Lyn kinase in eosinophils. More importantly, it activates Lyn kinase in an SH2- and SH3-dependent manner. Unc119 also binds to Hck but not to Itk or PI3K p110gamma . Furthermore, it does not interact with the SH2 or SH3 domains of Grb2 and Shc, respectively. The SH3 motif peptide of Unc119 activates both Lyn and Hck suggesting that a common principle is applicable to Unc119 interaction with SrcTKs. Interestingly Itk, which has both SH2 and SH3 domains, does not bind to nor is activated by Unc119. The results suggest the existence of microspecificity of SH3 interaction with their ligands.

Immunoprecipitation experiments suggest that only a small fraction of Unc119 is associated with Lyn in vivo (Fig. 3A). The result may suggest that this association is physiologically not important. However, because the binding of Unc119 leads to the activation of Lyn, it is likely that Unc119 associates with Lyn only transiently. Indeed, the association of Unc119 with Lyn increases after IL-5 stimulation (Fig. 5A). The Unc119-associated Lyn shows increased kinase activity. More importantly, the entire activable and detergent-soluble Lyn fraction is associated with Unc119 following IL-5 stimulation.

Unc119 (also known as HRG4 for human retinal gene protein 4) was originally cloned as a retina-specific gene (25). It had been localized in ribbon synapses of retina (35). It has 57% homology to the unc-119 gene from Caenorhabditis elegans, which is expressed in the neural tissue and is involved in feeding, locomotion, and chemosensation of the nematode (36). Recently, a single patient with cone-rod dystrophy who expressed a truncated form of HRG4 has been identified (37). This patient is heterozygous, and it is not clear from the report whether this patient displays any other abnormalities. Rhodopsin promoter-driven overexpression of this truncated HRG4 in the retina causes its degeneration in mice (37). The foregoing observation is exciting and clearly indicates an important role for HRG4/Unc119 in retina. However, the exact function of HRG4/Unc119 in retina and other organs remains unknown.

Crystallographic studies predict that the binding of the SH3 domain to an external SH3 ligand would release the linker region leading to a conformational change in the kinase domain and its activation. Indeed, studies using human immunodeficiency virus Nef, an exogenous SH3 ligand, have demonstrated robust activation of SrcTKs in vitro (14). Nef is not the only SH3 ligand that activates SrcTKs. Two cell surface receptors, CD28 and CD2, have proline-rich sequences that conform to the SH3-binding motif. In support of our findings both CD28 and CD2 activate Lck and Fyn, respectively, in an SH3 motif-dependent manner (31). Heterotrimeric guanine nucleotide-binding regulatory protein (G protein) can directly activate Src and Hck (38). Unc119 is not the first molecule that binds an Src-type kinase at two sites and regulates its function. It has been shown that p130Cas (Csk-associated substrate) binds Src kinase through its SH2 and SH3 domains (39). The binding through the SH3 domain activates Src. A mutation in the SH3-binding motif of p130Cas causes significant reduction in Src kinase activity (39). We have seen activation of Lyn by both SH2 and SH3 peptides. However, higher concentrations of the SH2 peptide are needed to activate Lyn. We speculate that the SH3-binding motif may be physiologically more relevant than the SH2-binding motif for Lyn activation.

Unc119 and Unc119-derived motif peptides induce autophosphorylation of Lyn as well as kinase activity for the substrate. However, we have observed that autophosphorylation occurs at a concentration of Unc119 that is frequently lower than required for the induction of kinase activity. The discrepancy between autophosphorylation and substrate phosphorylation has been noted previously by other investigators (40). The interplay between autophosphorylation and kinase activity of SrcTKs is very complex and is dependent upon multiple factors including divalent cation and ATP concentrations and affinity for substrates and activators. This complex process was recently investigated by Sun et al. (41), who demonstrated that autophosphorylation of Src is inhibited during the peak of substrate phosphorylation.

One of the important functions of IL-5 and other growth factors is to delay eosinophil apoptosis and prolong eosinophil survival. Lyn kinase has been shown previously (19, 20) to play a non-redundant role in this process. Inhibition of Lyn blocks eosinophil survival. When transduced into eosinophils Unc119 activated Lyn kinase and inhibited eosinophil apoptosis in the absence of growth factors. The anti-Unc119 antibody blocks eosinophil survival suggesting that Unc119 is important for Lyn activation in vivo. In other work2 we have demonstrated that overexpression of Unc119 induces activation of Lck and Fyn in T cells. Unc119-deficient cells are unable to activate Lck and Fyn following T cell stimulation. As a consequence these cells are unable to produce IL-2 and proliferate poorly. Thus, Unc119 appears to be a receptor-associated activator of SrcTKs. We believe that in eosinophils Unc119 and Lyn form an inactive complex with IL-5Ralpha under basal conditions, and Unc119 is inaccessible to the Lyn SH3 domain. Receptor activation changes the conformation allowing the association of Unc119 with the Lyn SH3 domain and leading to kinase activation. The association through the SH2 domain may have an additive effect. By activating SrcTKs Unc119 may provide a novel signal-generating mechanism for receptors and, therefore, may have broad biological relevance.

    ACKNOWLEDGEMENTS

We thank Dr. J. Tavernier for the IL-5Ralpha cDNA and Dr. G. Inana for a sample of anti-HRG4 antibody.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grants AI PO1 46004, ES06676, and AI50179, the John Sealy Memorial Fund, and the McLaughlin Fellowship Fund.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported in part by Harran University, SanliUrfa, Turkey.

|| To whom correspondence should be addressed: National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206. E-mail: alamr@njc.org.

Published, JBC Papers in Press, December 19, 2002, DOI 10.1074/jbc.M208261200

2 M. Gorska, S. J. Stafford, and R. Alam, submitted for publication.

    ABBREVIATIONS

The abbreviations used are: SrcTKs, Src family tyrosine kinases; IL, interleukin; HRG4, human retinal gene protein 4; SH2, Src homology 2 domain; SH3, Src homology 3 domain; GST, glutathione S-transferase; PBS, phosphate-buffered saline; RT, reverse transcribed; PVDF, polyvinylidene difluoride; FITC, fluorescein isothiocyanate; HSA, human serum albumin; PI3K, phosphatidylinositol 3-kinase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Sefton, B. M., and Taddie, J. A. (1994) Curr. Opin. Immunol. 6, 372-379[CrossRef][Medline] [Order article via Infotrieve]
2. DeFranco, A. L. (1995) Curr. Opin. Cell Biol. 7, 163-175[CrossRef][Medline] [Order article via Infotrieve]
3. Liu, X., Brodeur, S. R., Gish, G., Songyang, Z., Cantley, L. C., Laudano, A. P., and Pawson, T. (1993) Oncogene 8, 1119-1126[Medline] [Order article via Infotrieve]
4. McFarland, E. D., Hurley, T. R., Pingel, J. T., Sefton, B. M., Shaw, A., and Thomas, M. L. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1402-1406[Abstract]
5. Hurley, T. R., Hyman, R., and Sefton, B. M. (1993) Mol. Cell. Biol. 13, 1651-1656[Abstract]
6. Katagiri, T., Ogimoto, M., Hasegawa, K., Arimura, Y., Mitomo, K., Okada, M., Clark, M. R., Mizuno, K., and Yakura, H. (1999) J. Immunol. 163, 1321-1326[Abstract/Free Full Text]
7. Yanagi, S., Sugawara, H., Kurosaki, M., Sabe, H., Yamamura, H., and Kurosaki, T. (1996) J. Biol. Chem. 271, 30487-30492[Abstract/Free Full Text]
8. Roach, T., Slater, S., Koval, M., White, L., Cahir McFarland, E. D., Okumura, M., Thomas, M., and Brown, E. (1997) Curr. Biol. 7, 408-417[Medline] [Order article via Infotrieve]
9. Xu, W., Doshi, A., Lei, M., Eck, M. J., and Harrison, S. C. (1999) Mol. Cell 3, 629-638[Medline] [Order article via Infotrieve]
10. Sicheri, F., Moarefi, I., and Kuriyan, J. (1997) Nature 385, 602-609[CrossRef][Medline] [Order article via Infotrieve]
11. Young, M. A., Gonfloni, S., Superti-Furga, G., Roux, B., and Kuriyan, J. (2001) Cell 105, 115-126[Medline] [Order article via Infotrieve]
12. Alexandropoulos, K., Cheng, G., and Baltimore, D. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 3110-3114[Abstract]
13. Rickles, R. J., Botfield, M. C., Weng, Z., Taylor, J. A., Green, O. M., Brugge, J. S., and Zoller, M. J. (1994) EMBO J. 13, 5598-5604[Abstract]
14. Moarefi, I., LaFevre-Bernt, M., Sicheri, F., et al.. (1997) Nature 385, 650-653[CrossRef][Medline] [Order article via Infotrieve]
15. Tavernier, J., Devos, R., Cornelis, S., Tuypens, T., Van der Heyden, J., Fiers, W., and Plaetinck, G. (1991) Cell 66, 1175-1184[Medline] [Order article via Infotrieve]
16. Coffer, P. J., Schweizer, R. C., Dubois, G. R., Maikoe, T., Lammers, J. W., and Koenderman, L. (1998) Blood 91, 2547-2557[Abstract/Free Full Text]
17. Pazdrak, K., Schreiber, D., Forsythe, P., Justement, L., and Alam, R. (1995) J. Exp. Med. 181, 1827-1834[Abstract]
18. Pazdrak, K., Stafford, S., and Alam, R. (1995) J. Immunol. 155, 397-402[Abstract]
19. Pazdrak, K., Olszewska-Pazdrak, B., Stafford, S., Garofalo, R. P., and Alam, R. (1998) J. Exp. Med. 188, 421-429[Abstract/Free Full Text]
20. Yousefi, S., Hoessli, D. C., Blaser, K., Mills, G. B., and Simon, H. U. (1996) J. Exp. Med. 183, 1407-1414[Abstract]
21. Stafford, S., Lowell, C., Sur, S., and Alam, R. (2002) J. Immunol. 168, 1978-1983[Abstract/Free Full Text]
22. Robzyk, K., and Kassir, Y. (1992) Nucleic Acids Res. 20, 3790[Medline] [Order article via Infotrieve]
23. Dower, W. J., Miller, J. F., and Ragsdale, C. W. (1988) Nucleic Acids Res. 16, 6127-6145[Abstract]
24. Coligan, E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M., and Strober, W. (eds) (1991) Current Protocols in Immunology , pp. 2.4.1-2.4.5, John Wiley & Sons, Inc., New York
25. Higashide, T., and Inana, G. (1999) Genomics 57, 446-450[CrossRef][Medline] [Order article via Infotrieve]
26. Songyang, Z., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofsky, S., and Lechleider, R. J. (1993) Cell 72, 767-778[Medline] [Order article via Infotrieve]
27. Li, S. C., Gish, G., Yang, D., Coffey, A. J., Forman-Kay, J. D., Ernberg, I., Kay, L. E., and Pawson, T. (1999) Curr. Biol. 9, 1355-1362[CrossRef][Medline] [Order article via Infotrieve]
28. Joung, I., Strominger, J. L., and Shin, J. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 5991-5995[Abstract/Free Full Text]
29. Poy, F., Yaffe, M. B., Sayos, J., Saxena, K., Morra, M., Sumegi, J., Cantley, L. C., Terhorst, C., and Eck, M. J. (1999) Mol. Cell 4, 555[Medline] [Order article via Infotrieve]
30. Lang, V., Semichon, M., Michel, F., Brossard, C., Gary-Gouy, H., and Bismuth, G. (1999) J. Immunol. 162, 7224[Abstract/Free Full Text]
31. Holdorf, A. D., Green, J. M., Levin, S. D., Denny, M. F., Straus, D. B., Link, V., Changelian, P. S., Allen, P. M., and Shaw, A. S. (1999) J. Exp. Med. 190, 375-384[Abstract/Free Full Text]
32. Morris, M. C., Depollier, J., Mery, J., Heitz, F., and Divita, G. (2001) Nat. Biotechnol. 19, 1173-1176[CrossRef][Medline] [Order article via Infotrieve]
33. Burg, D. L., Furlong, M. T., Harrison, M. L., and Geahlen, R. L. (1994) J. Biol. Chem. 269, 28136-28142[Abstract/Free Full Text]
34. Yamashita, T., Mao, S. Y., and Metzger, H. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11251-11255[Abstract/Free Full Text]
35. Higashide, T., McLaren, M. J., and Inana, G. (1998) Investig. Ophthalmol. Vis. Sci. 39, 690-698[Abstract]
36. Maduro, M. (1995) Genetics 141, 977-988[Abstract/Free Full Text]
37. Kobayashi, A., Higashide, T., Hamasaki, D., Kubota, S., Sakuma, H., An, W., Fujimaki, T., McLaren, M. J., Weleber, R. G., and Inana, G. (2000) Investig. Ophthalmol. Vis. Sci. 41, 3268-3277[Abstract/Free Full Text]
38. Ma, Y. C., Huang, J., Ali, S., Lowry, W., and Huang, X. Y. (2000) Cell 102, 635-646[Medline] [Order article via Infotrieve]
39. Nakamoto, T., Sakai, R., Ozawa, K., Yazaki, Y., and Hirai, H. (1996) J. Biol. Chem. 271, 8959-8965[Abstract/Free Full Text]
40. Singh, R. A., Zang, Y. C., Shrivastava, A., Hong, J., Wang, G. T., Li, S., Tejada-Simon, M. V., Kozovska, M., Rivera, V. M., and Zhang, J. Z. (1999) J. Immunol. 163, 6393-6402[Abstract/Free Full Text]
41. Sun, G., Ramdas, L., Wang, W., Vinci, J., McMurray, J., and Budde, R. J. (2002) Biochem. Biophys. 397, 11-17[CrossRef]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.